Cost of one month of treatment with Sorafenib/Nexavar

Sorafenib/Nexavar (Sorafenib) is a targeted anti-tumor drug widely used in the treatment of liver cancer, kidney cancer and thyroid cancer. Since its introduction into the Chinese market, it has become one of the commonly used oral targeted drugs in clinical practice due to its clear therapeutic effect and mature usage experience. The current recommended standard usage is oral administration of 0.4 grams twice daily (i.e. 2 tablets of 200 mg), which is equivalent to a daily dose of 800 mg. A box of the original drug sorafenib usually contains 60 tablets of 0.2g, which is exactly half a month’s supply. Domestically, the original drug has been included in the national medical insurance catalog and has been reimbursed by medical insurance in many places, greatly reducing the financial burden on patients.

Before it is included in medical insurance, the price of sorafenib is relatively expensive for ordinary patients. The market price of a box (60 tablets) is about 6,000 yuan, and the monthly treatment cost can reach more than 1000 yuan. However, under the coverage of medical insurance, the patient's out-of-pocket expenses drop significantly, which varies according to local reimbursement policies. In addition, some public welfare assistance projects or charitable foundations provide "drug donation" support, which is an important auxiliary channel for patients with limited financial conditions.

In addition to the original drugs marketed in China, there are also multiple generic versions in overseas markets, especially Indian generic drugs are the most representative. The price of the Indian version of sorafenib is much lower than that of the original drug, and the monthly cost may only be around 900 yuan, or even lower. Most of these generic drugs claim to be similar to the original drugs in terms of ingredients and bioequivalence. In terms of efficacy guarantee and drug traceability, the original drugs still have higher safety and standardization.

Generally speaking, the monthly treatment cost of sorafenib is affected by multiple factors. During the treatment process, patients should give priority to obtaining drugs through formal medical channels and use the drugs under the guidance of professional doctors to ensure both efficacy and safety.

Reference materials:https://www.nexavar.com/